by Brian Wang on (#56MRZ)
Eli Lilly a Phase 3 trial studying LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff at long-term care facilities in the U.S. (skilled nursing facilities,...
| Link | https://www.nextbigfuture.com/ |
| Feed | http://feeds.feedburner.com/blogspot/advancednano |
| Updated | 2025-11-21 02:30 |